Publications by authors named "Xu-Rong Jiang"

Claim this Profile
C
Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding.
Xiaojun Lu, Lee Ann Machiesky, Niluka De Mel, Qun Du, Weichen Xu, Xu-Rong Jiang

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics.
Bonnie Wu, Shan Chung, Xu-Rong Jiang, Jim McNally, Joao Pedras-Vasconcelos

AAPS J· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of parallelism testing for four-parameter logistic model in bioassays.
Harry Yang, Hyun Jun Kim, Lanju Zhang, Robert J Strouse, Mark Schenerman, Xu-Rong Jiang

PDA J Pharm Sci Technol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
Yuling Wu, Jia J Li, Hyun Jun Kim, Xu Liu, Weiyi Liu, Xu-Rong Jiang

AAPS J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the assessment and control of the effector functions of therapeutic antibodies.
Xu-Rong Jiang, An Song, Svetlana Bergelson, Thomas Arroll, Bhavin Parekh

Nat Rev Drug Discov· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity.
Douglas D Banks, Himanshu S Gadgil, Gary D Pipes, Pavel V Bondarenko, Vipa Hobbs, Xu-Rong Jiang

J Pharm Sci· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase.
Ngaire J Elwood, Xu-Rong Jiang, Choy-Pik Chiu, Jane S Lebkowski, Clayton A Smith

Haematologica· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis